BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 13, 2010
 |  BioCentury  |  Strategy

Unwinding Biovail's Deals

Unwinding Biovail's Deals

Deal date Partner Product Product description Product status Deal status Deal terms
Jun-10 Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151) Istradefylline Adenosine A2A receptor (ADORA2A) antagonist FDA not approvable letter in 2008 for an NDA to treat idiopathic Parkinson's disease (PD) Ongoing;...

Read the full 339 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >